Oct 11 (Reuters) - ProMIS Neurosciences Inc PMN.TO :
* PROMIS NEUROSCIENCES IDENTIFIES NOVEL ANTIBODY DRUG CANDIDATES FOR PARKINSON'S DISEASE
* PROMIS NEUROSCIENCES - IDENTIFICATION OF SEVERAL POTENTIAL ANTIBODY THERAPEUTIC CANDIDATES AIMED AT TARGETING TOXIC OLIGOMERS OF PROTEIN Α-SYNUCLEIN